Skip to main content

Dodge & Cox

Position in NBIX — Neurocrine Biosciences Inc

CIK 200217 San Francisco, CA

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$941,246,517
+$221,809,503 QoQ
Shares Held
5,584,707
+2.3% QoQ
Ownership
5.49%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#3
of 774 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Dodge & Cox holds $3,998,776,252 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (23.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
5,584,707 $941,246,517

All Filings in NBIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $941,246,517 5,584,707
2026-03-31 $719,437,014 5,461,037
2025-12-31 $781,205,596 5,508,042
2025-09-30 $780,038,034 5,556,618
2025-06-30 $699,692,851 5,566,814
2025-03-31 $612,129,414 5,534,624
2024-12-31 $411,742,012 3,016,425
2024-09-30 $148,382,620 1,287,820
2024-06-30 $176,330,489 1,280,820
2024-03-31 $174,502,452 1,265,244
2023-12-31 $165,983,869 1,259,744
2023-09-30 $24,030,225 213,602